Filing Flows › Longevity Health Holdings (XAGE) › Q2 2025
Longevity Health Holdings (XAGE) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Longevity Health Holdings (XAGE) reported revenue of $504K for the second quarter 2025 (Q2 2025), up 41-fold from a year earlier and -1% from the quarter before. Operating margin was -369.1%, net loss $1.9M (374.6% of revenue).
Longevity Health Holdings, Q2 2025: revenue $504K (41× year over year), operating margin -369.1%, net loss $1.9M, operating cash flow −$836K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $504K | -1% | 41× |
| Operating profit | −$1.9M | — | — |
| Net earnings | −$1.9M | — | — |
| Operating cash flow | −$836K | — | — |
What changed
Revenue was $504K in Q2 2025, up 3988% year over year and down 1% from the previous quarter.
Gross margin was 60.1%, down 37.5 points from a year earlier. Operating costs exceeded revenue by $1.9M, an operating margin of -369.1%. Operating expenses grew 80% against revenue growth of 3988%. The fastest-growing cost line was Sales & marketing (+3028%). The quarter ended with a net loss of $1.9M, wider than the previous quarter's $1.5M loss.
Operating cash flow was −$836K. Non-cash charges added back $22K of depreciation and amortization and $194K of share-based compensation. Working capital and other items added $834K.
Questions
What was Longevity Health Holdings' revenue in the second quarter 2025?
Longevity Health Holdings (XAGE) reported revenue of $504K for the second quarter 2025 (Q2 2025), up 41-fold from a year earlier and -1% from the quarter before.
Was Longevity Health Holdings profitable in the second quarter 2025?
Operating loss was $1.9M (-369.1% of revenue) and net loss $1.9M.